Lucid Diagnostics (LUCD) Operating Leases (2022 - 2026)

Lucid Diagnostics' Operating Leases history runs 5 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• Quarterly Operating Leases fell 35.1% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 35.1% YoY) and the FY2025 annual result came in at $927000.0, down 65.07% from the prior year.
• Operating Leases was $1.6 million for Q1 2026 at Lucid Diagnostics, up from $927000.0 in the prior quarter.
• Across five years, Operating Leases topped out at $2.7 million in Q4 2024 and bottomed at $177000.0 in Q1 2024.
• A 5-year average of $1.5 million and a median of $1.6 million in 2023 frame the typical range for Operating Leases.
• Annual changes were most pronounced in 2023 — Operating Leases sank 80.81% — and 2025, when it soared 1295.48%.
• Lucid Diagnostics' Operating Leases stood at $1.0 million in 2022, then sank by 80.81% to $199000.0 in 2023, then surged by 1233.67% to $2.7 million in 2024, then plunged by 65.07% to $927000.0 in 2025, then jumped by 72.92% to $1.6 million in 2026.
• Business Quant data shows LUCD's Operating Leases at $1.6 million in Q1 2026, $927000.0 in Q4 2025, and $2.0 million in Q3 2025.